| Sarah Norene Pletcher, MD | |
|
Dartmouth Hitchcock Medical Center, Lebanon, NH 03756 | |
| (603) 650-5000 | |
| Not Available |
| Full Name | Sarah Norene Pletcher |
|---|---|
| Gender | Female |
| Speciality | Surgery |
| Location | Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1609969112 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | 1466 (New Hampshire) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Sarah Norene Pletcher, MD 1183 Union Village Road, Norwich, VT 05055 Ph: (802) 649-1066 | Sarah Norene Pletcher, MD Dartmouth Hitchcock Medical Center, Lebanon, NH 03756 Ph: (603) 650-5000 |
News Archive
A new study reports that a loss of genes on chromosome 1 or chromosome 11 raises the risk of death from the children's cancer neuroblastoma, even when other indicators seem to point to a lower-risk form of the disease.
Living Cell Technologies Limited, a company pioneering the development of a cell implant to treat diabetes, has obtained approval to commence a Phase II DIABECELL clinical trial in Buenos Aires, Argentina, DIABECELL's third jurisdiction to date which has approved human trials. Up to eight adult patients with Type 1 diabetes, including those with unstable diabetes and severe hypoglycaemia, will each receive two implants of DIABECELL, three months apart with a dose seeking component. The trial is expected to begin in the second half of this year.
A new compound that targets anaplastic lymphoma kinase-positive (ALK+) non-small cell lung cancer is well-tolerated by patients and is already showing early signs of activity, including in patients who no longer respond to crizotinib-the only approved ALK inhibitor. Results of this Novartis-sponsored sudy will be presented by a researcher from Fox Chase Cancer Center during the 2012 Annual Meeting of the American Society of Clinical Oncology on Sunday, June 3.
CSL Behring today presented data from a Phase I/III study on the efficacy and safety of its novel investigational recombinant factor VIII single chain in adolescents and adults with hemophilia A during a late breaking abstract session at the 2015 International Society on Thrombosis and Haemostasis (ISTH) Congress.
A new report has revealed that the simplification of complex nutritional messages has resulted in grain foods like bread and pasta becoming the ‘scapegoat' for weight gain and bloating, despite ample research to the contrary.
› Verified 6 days ago
Nikolaos Zacharias, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Dr, Vascular Surgery, Lebanon, NH 03756 Phone: 603-650-8677 | |
Juliana Castellano, MD, PHD Surgery Medicare: Accepting Medicare Assignments Practice Location: One Medical Center Dr, Lebanon, NH 03756 Phone: 603-650-8693 | |
Gina Lynn Adrales, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Dr, Lebanon, NH 03756 Phone: 603-650-8113 Fax: 603-650-8030 | |
Astrid Gleaton, M.D. Surgery Medicare: Medicare Enrolled Practice Location: 1 Medical Center Dr, Lebanon, NH 03756 Phone: 603-650-5000 | |
Stefanie Sueda, Surgery Medicare: Medicare Enrolled Practice Location: 1 Medical Center Dr, Lebanon, NH 03756 Phone: 603-650-5000 | |
Dr. James C Cooros, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Dr, Lebanon, NH 03756 Phone: 603-650-8050 | |
Dr. David H Stone, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Dr, Dhmc Department Of Surgery, Lebanon, NH 03756 Phone: 603-650-4682 Fax: 603-650-4973 |